查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1799200

全球智慧植入幫浦市場

Smart Implantable Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球智慧植入幫浦市場規模將達到 36 億美元

全球智慧植入幫浦市場規模預計在2024年為27億美元，到2030年將達到36億美元，2024年至2030年的複合年成長率為5.3%。智慧灌溉幫浦是本報告分析的細分市場之一，預計其複合年成長率為4.2%，到分析期結束時規模將達到22億美元。智慧微泵細分市場在分析期間的複合年成長率預計為7.2%。

美國市場規模估計為 6.976 億美元，中國市場預計複合年成長率為 5.3%

美國智慧植入幫浦市場規模預計在2024年達到6.976億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到5.859億美元，在分析期間（2024-2030年）的複合年成長率為5.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為4.8%和4.6%。在歐洲，德國的複合年成長率預計為4.4%。

全球智慧植入幫浦市場—主要趨勢與促進因素摘要

智慧植入幫浦將如何改變慢性病治療？

智慧植入式幫浦透過提供可程式設計、精準、持續的輸注功能，徹底改變了藥物和治療劑向人體的傳遞方式。與體外或手動輸送方式不同，這些小型生物相容性裝置可透過手術植入皮下或腔內，確保以最少的患者介入實現有針對性的長期治療。它們對於治療疼痛、痙攣、糖尿病、癌症和心血管疾病等慢性疾病至關重要，因為持續的劑量和對生理回饋的反應至關重要。

智慧植入式幫浦與傳統系統的差異在於其整合了感測器、微處理器和無線遙測技術，因此可以進行即時調整、資料登錄和臨床醫生監測。患者不再需要遵守嚴格的給藥方案，也不再需要忍受傳統藥物治療方案的劑量波動。相反，這些系統可以根據生物訊號調整劑量，從而改善療效並減少副作用。它們還消除了頻繁就診的需要，使其成為遠端醫療和個人化醫療的基石。

下一代植入式輸送系統背後有何技術？

現代智慧泵融合了電子機械系統 (MEMS)、無線通訊、低功耗設計和生物相容性材料。 MEMS 技術在不影響功能性的情況下實現了微型化，使幫浦能夠透過微創手術安全地植入和補充。一些幫浦配備了壓力和流量感測器，可以監測輸液精度、檢測堵塞情況並回應患者的生理變化。

無線遠端檢測可透過手持式程式設計器或支援藍牙的智慧型手機，在裝置與外部讀取器或臨床醫生介面之間實現雙向通訊。臨床醫生可以遠端監控用藥歷史、電池壽命和設備功能，甚至可以即時調整劑量。可充電電池、感應式充電技術和能源採集機制可延長設備壽命，並減少手術介入的需求。與雲端基礎健康平台整合，可實現長期數據追蹤，為臨床決策提供支援。

智慧植入幫浦在哪些方面有最大的臨床影響？

這些設備在腫瘤學領域帶來了改變生命的益處，持續輸注化療藥物可以更好地針對腫瘤，同時降低全身毒性。在疼痛管理方面，智慧型幫浦鞘內給藥是鴉片類藥物的強效替代方案，可最大限度地減少對藥物的依賴，並改善頑固性疼痛患者的生活品質。對於痙攣性疼痛，例如多發性硬化症和腦性麻痹，智慧Baclofen幫浦可實現精準的靶向神經調節。

雖然體外胰島素幫浦仍是糖尿病治療的主流，但植入式胰島素幫浦正逐漸興起，用於長期血糖管理，尤其是與連續血糖監測儀 (CGM) 結合使用。心臟病學是另一個蓬勃發展的領域，目前正在開發用於控制輸送抗凝血劑、抗高血壓藥物和抗心律不整藥物的智慧幫浦。此外，人們正在探索透過植入式輸注系統進行顱內標靶給藥，以治療帕金森氏症和阿茲海默症神經退化性疾病。

智慧植入幫浦市場的成長受到多種因素的推動…

由於全球慢性病和文明病的增多，需要持續治療和高度標靶治療，市場正在迅速擴張。微型化、電源管理、遙測和藥物儲庫材料的技術進步正在提高設備的使用壽命、安全性和反應速度。對遠端患者監護、醫院-居家照護模式以及個人化治療通訊協定的需求日益成長，也提升了智慧自主給藥系統的吸引力。

此外，優惠的報銷框架、對數位療法的監管支持以及臨床醫生對植入式設備的日益熟悉，正在降低其應用門檻。醫療科技公司、數位健康平台和製藥公司之間的合作也推動了基於幫浦的給藥模式的創新。隨著醫療保健系統優先考慮患者依從性、基於療效的護理和具有成本效益的慢性病管理，智慧植入式幫浦有望成為下一代療法的基礎要素。

部分

幫浦類型（智慧灌注幫浦、智慧微型幫浦）、應用（疼痛應用、痙攣應用、心血管應用、其他應用）、最終用途（醫院最終用途、門診手術中心最終用途、其他最終用途）

受訪公司範例

  • Abbott Laboratories
  • Abiomed（Johnson & Johnson）
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson（other implants）
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP39353

Global Smart Implantable Pumps Market to Reach US$3.6 Billion by 2030

The global market for Smart Implantable Pumps estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Smart Perfusion Pumps, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Smart Micro Pumps segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$697.6 Million While China is Forecast to Grow at 5.3% CAGR

The Smart Implantable Pumps market in the U.S. is estimated at US$697.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$585.9 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Smart Implantable Pumps Market - Key Trends & Drivers Summarized

How Are Smart Implantable Pumps Transforming Chronic Disease Therapy?

Smart implantable pumps are revolutionizing the delivery of medications and therapeutic agents within the human body by providing programmable, precise, and continuous infusion capabilities. Unlike external or manual delivery methods, these miniature, biocompatible devices are surgically placed under the skin or within body cavities to ensure targeted, long-term treatment with minimal patient intervention. They are critical for managing chronic conditions such as pain, spasticity, diabetes, cancer, and cardiovascular diseases, where consistent dosing and responsiveness to physiological feedback are essential.

What differentiates smart implantable pumps from legacy systems is their integration with sensors, microprocessors, and wireless telemetry, enabling real-time adjustments, data logging, and clinician oversight. Patients no longer need to adhere to strict dosing schedules or tolerate the peaks and troughs of conventional drug regimens. Instead, these systems can titrate doses based on biological signals, improving therapeutic outcomes and reducing side effects. They also eliminate the need for frequent hospital visits, making them a linchpin of remote and personalized healthcare.

What Technologies Are Powering Next-Generation Implantable Delivery Systems?

The modern smart pump is a convergence of microelectromechanical systems (MEMS), wireless communication, low-power electronics, and biocompatible materials. MEMS technology enables miniaturization without compromising functionality, allowing pumps to be safely implanted and refilled through minimally invasive procedures. Some pumps are equipped with pressure and flow sensors that monitor infusion accuracy, detect occlusions, or adjust for changes in patient physiology.

Wireless telemetry allows two-way communication between the device and external readers or clinician interfaces, often via handheld programmers or Bluetooth-enabled smartphones. Physicians can remotely monitor dosage history, battery life, and device function-and even make dosing adjustments in real time. Rechargeable batteries, inductive charging technologies, and energy harvesting mechanisms are enabling longer device lifespans and fewer surgical interventions. Integration with cloud-based health platforms allows longitudinal data tracking for clinical decision support.

Where Are Smart Implantable Pumps Making the Most Clinical Impact?

These devices are delivering life-changing benefits in oncology, where continuous infusion of chemotherapeutics can increase tumor targeting while reducing systemic toxicity. In pain management, intrathecal drug delivery via smart pumps offers a powerful alternative to opioids, minimizing dependence and improving quality of life for patients with intractable pain. For spasticity in conditions like multiple sclerosis and cerebral palsy, smart baclofen pumps allow precise, targeted neuromodulation.

In diabetes care, while external insulin pumps dominate, implantable versions are gaining ground for long-term glucose management, especially when coupled with continuous glucose monitors (CGMs). Cardiology is another growing frontier, with smart pumps under development for the controlled delivery of anticoagulants, antihypertensives, and anti-arrhythmic agents. Additionally, investigational applications in neurodegenerative disorders, such as Parkinson’s and Alzheimer’s disease, involve targeted intracranial delivery of therapeutics via implantable infusion systems.

The Growth in the Smart Implantable Pumps Market Is Driven by Several Factors…

The market is expanding rapidly due to rising global prevalence of chronic and lifestyle-related diseases requiring continuous or highly targeted therapy. Technological advancements in miniaturization, power management, telemetry, and drug reservoir materials are enhancing device longevity, safety, and responsiveness. Increasing demand for remote patient monitoring, hospital-at-home care models, and personalized treatment protocols is reinforcing the appeal of smart, autonomous delivery systems.

Furthermore, favorable reimbursement frameworks, regulatory support for digital therapeutics, and growing clinician familiarity with implantable devices are reducing adoption barriers. Collaborations between medtech firms, digital health platforms, and pharmaceutical companies are also fostering innovation in pump-enabled drug delivery models. As healthcare systems prioritize patient adherence, outcome-based care, and cost-effective chronic disease management, smart implantable pumps are poised to become a foundational element of next-generation therapeutics.

SCOPE OF STUDY:

The report analyzes the Smart Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Pump Type (Smart Perfusion Pumps, Smart Micro Pumps); Application (Pain Application, Spasticity Application, Cardiovascular Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed (Johnson & Johnson)
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson (other implants)
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Smart Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Disease Management Needs Propels Demand for Implantable Drug Delivery Devices
    • Miniaturization and Biocompatibility Advancements Drive Adoption of Smart Implantable Pumps
    • Integration with Remote Monitoring Platforms Strengthens Case for Connected Drug Delivery Systems
    • Increased Use of Closed-Loop Systems in Diabetes Management Expands Addressable Market
    • Clinical Shift Toward Targeted and Personalized Therapies Spurs Smart Pump Innovation
    • Surge in Demand for Pain Management Solutions Drives Interest in Programmable Intrathecal Pumps
    • Expansion of Wearables and Implantables Ecosystems Supports Smart Pump Interoperability
    • Real-Time Data Feedback Loops Enable Adaptive Dosing and Improved Patient Outcomes
    • Improved Battery Life and Wireless Charging Capabilities Enhance Patient Comfort and Compliance
    • Remote Software Updates and Physician Control Platforms Drive Clinical Utility
    • Growth of Home-Based Infusion Therapy Creates Demand for Safe, Long-Term Implantable Delivery
    • Regulatory Support for Digital Therapeutics Encourages Smart Pump Innovation in Niche Therapies
    • Collaborations Between MedTech and Biopharma Firms Fuel Innovation in Combination Delivery Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Smart Perfusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Smart Perfusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Smart Micro Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Smart Micro Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pain Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Pain Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spasticity Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Spasticity Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION